DC162-Pain Assessment and Management Policy

Registration Number: {{org_field_registration_no}}

Pain Assessment and Management Policy

1. Purpose

The purpose of this policy is to establish a structured, effective, and compassionate approach to pain assessment and management within our domiciliary care service. Our organisation is committed to ensuring that service users receive appropriate, timely, and evidence-based pain management interventions that enhance their quality of life and overall well-being. By implementing clear guidelines and training for staff, we ensure that pain is accurately assessed, documented, and addressed in a person-centred manner, aligning with Care Quality Commission (CQC) requirements and best practice standards.

2. Scope

This policy applies to all care staff, including domiciliary care workers, registered managers, healthcare professionals, and any other individuals involved in the care and support of service users experiencing pain. It covers:

The identification and assessment of pain.
Person-centred pain management strategies.
Documentation and record-keeping.
Staff training and competency.
Monitoring and continuous improvement of pain management practices.
Compliance with legal and regulatory frameworks.

3. Legal and Regulatory Framework

This policy supports compliance with the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 and associated CQC guidance, including (but not limited to):

Regulation 9 (Person-centred care): pain assessment and management must be individualised, reflected in the care plan, and reviewed.
Regulation 10 (Dignity and respect): pain must be taken seriously, responded to promptly, and managed in a way that respects privacy and preferences.
Regulation 11 (Need for consent): valid consent must be obtained for pain assessment and any pain management interventions; where capacity is in doubt, Mental Capacity Act processes must be followed and recorded.
Regulation 12 (Safe care and treatment): providers must assess risks, take all reasonably practicable steps to mitigate them, and prevent avoidable harm (including harm related to unmanaged pain, medication errors, adverse effects, and unsafe non-pharmacological interventions).
Regulation 13 (Safeguarding): unmanaged pain, inappropriate withholding of pain relief, coercion, neglect, or medication misuse may constitute abuse/neglect and must be reported and escalated in line with safeguarding procedures.
Regulation 17 (Good governance): accurate records, audit, learning, and service improvement are required to demonstrate safe pain assessment and management.
Regulation 18 (Staffing): staff must be suitably trained and competent for their role in recognising, documenting, escalating and (where authorised) supporting medicines-related pain management.
Regulation 20 (Duty of candour): when a notifiable safety incident occurs (e.g., medicine error causing harm, avoidable delay in escalation resulting in harm), the service must be open and transparent, provide an apology, and keep clear written records of actions taken.

This policy also aligns with:

Mental Capacity Act 2005 (including best-interests decision-making and documentation where applicable).
Human Medicines Regulations 2012 and national medicines safety expectations relevant to domiciliary care (including PRN administration, monitoring for adverse effects and escalation).
NICE guidance relevant to pain assessment/management (including chronic pain guidance NG193 and other condition-specific guidance where applicable) and the organisation’s Medication Management Policy.
CQC’s current assessment approach (Single Assessment Framework): we evidence compliance through relevant quality statements under Safe, Effective, Caring, Responsive and Well-led (e.g., safe systems, learning culture, person-centred planning, and governance).

4. Understanding Pain in the Context of Domiciliary Care

Pain is a complex and subjective experience that can affect every aspect of an individual’s daily life, particularly for older adults and those with long-term health conditions. Our approach recognises the following types of pain:

Acute pain: Sudden and temporary pain, often caused by injury or surgery.
Chronic pain: Persistent pain lasting longer than three months, commonly associated with arthritis, nerve damage, or degenerative conditions.
Neuropathic pain: Pain resulting from nerve damage or dysfunction.
Breakthrough pain: Episodes of severe pain that occur despite ongoing pain management strategies.

Service users may struggle to articulate their pain due to cognitive impairment, communication difficulties, or conditions such as dementia. Therefore, our staff are trained to identify both verbal and non-verbal indicators of pain.

5. Pain Assessment Procedures

To ensure a structured and accurate approach to pain assessment, our organisation employs the following methods:

5.1 Initial Pain Assessment

All new service users undergo a comprehensive pain assessment during their initial care planning.
Pain history, underlying medical conditions, and medication use are reviewed.
The severity, frequency, location, and characteristics of pain are documented using validated tools.

5.2 Ongoing Pain Monitoring

Regular pain assessments are conducted as part of daily care routines.
A person-centred approach is used, considering the individual’s preferred pain descriptions.
Any new or worsening pain is reported immediately to healthcare professionals.

5.3 Consent, Capacity and Communication

Before undertaking pain assessment and agreeing pain management actions, staff must obtain and record the person’s consent. Where there is reason to doubt capacity to consent, staff must follow the organisation’s Mental Capacity Act procedure, including assessing capacity for the specific decision, supporting the person to decide, and recording best-interests decisions (including involvement of family/advocates where appropriate).

Staff must make reasonable adjustments to enable people to communicate pain, including using preferred communication methods, accessible information, interpreters, and (where needed) validated observational tools (e.g., for dementia, learning disability, autism, sensory impairment, or speech/language difficulties).

5.4 Red Flags and Escalation (Deterioration / Uncontrolled Pain)

Staff must treat new, severe, sudden, unexplained, or rapidly worsening pain as a potential deterioration and escalate immediately. Examples include (not exhaustive): suspected fracture after a fall; chest pain; signs of stroke; severe abdominal pain; signs of sepsis; sudden severe headache; new neurological deficit; uncontrolled pain despite prescribed measures; suspected medication adverse reaction (e.g., opioid over-sedation, respiratory depression, confusion).

Escalation must follow the care plan and clinical advice pathways and may include contacting GP, district nurse, out-of-hours services, NHS 111, or emergency services (999) depending on urgency. All escalation actions, advice received, and outcomes must be recorded in the care record and communicated to relevant professionals/family (as appropriate and lawful).

5.5 Pain Assessment Tools

To ensure consistency and reliability, our care staff use standardised pain assessment tools, including:

Numeric Rating Scale (NRS): Service users rate pain on a scale from 0 (no pain) to 10 (worst possible pain).
Verbal Descriptor Scale (VDS): For individuals who prefer describing their pain using words such as mild, moderate, or severe.
Abbey Pain Scale: A validated tool for assessing pain in non-verbal individuals, including those with dementia.
Pain Faces Scale: Useful for individuals with communication difficulties.

6. Pain Management Strategies

Our organisation implements a holistic and multidisciplinary approach to pain management, ensuring that interventions are tailored to each service user’s needs and preferences.

6.1 Non-Pharmacological Approaches

Whenever appropriate, non-drug interventions are prioritised to manage pain, including:

Positioning and Mobility Support: Assisting service users with positioning and movement to alleviate discomfort.
Heat and Cold Therapy: Applying heat pads or cold packs (as prescribed) to reduce inflammation and muscle pain.
Massage and Relaxation Techniques: Gentle massage and guided relaxation exercises to ease pain and stress.
Cognitive Behavioural Therapy (CBT): Supporting service users in developing coping mechanisms for chronic pain.
Music and Distraction Techniques: Using music, reading, or engaging activities to divert attention from pain.

6.2 Safety Controls for Non-Pharmacological Interventions

Non-pharmacological interventions must only be used where they are included in the person’s care plan and have been risk assessed. Staff must check contraindications and risks, including skin integrity, circulation, neuropathy, cognitive impairment, infection risk, and the person’s ability to consent/withdraw consent.

Heat/cold therapy must follow manufacturer instructions and care plan guidance (temperature, duration, protective covering, skin checks before/during/after) and must not be applied to broken skin or where reduced sensation or impaired circulation increases burn/frostbite risk. Any adverse effects (redness, blistering, increased pain) must be recorded and escalated.

6.3 Pharmacological Approaches

Domiciliary care staff must follow the organisation’s Medication Management Policy and only provide medicines support within their training, competence and authorisation (e.g., prompting, assisting, or administering where commissioned and assessed as safe). Staff must never alter doses, timings, or formulations, or give “extra” pain relief outside the prescriber’s directions.

Where the person has PRN (“as required”) analgesia, staff may only administer PRN medicines when there is a clear, written PRN protocol (in the MAR/care plan) specifying: indication (what pain/when to use), minimum interval, maximum daily dose, expected effect, key risks and monitoring (e.g., sedation, constipation), and when to escalate to a clinician if pain persists. The reason for PRN use and the effectiveness review must be documented each time.

For higher-risk analgesics (including opioids, gabapentinoids, and medicines with sedation risk), staff must monitor and document relevant adverse effects and red flags (e.g., excessive drowsiness, confusion, falls risk, constipation, nausea/vomiting) and escalate promptly if concerns arise.

If a medicines error, refusal, omission, or supply issue occurs, staff must follow the medicines incident process, obtain clinical advice where required, record actions taken, and consider whether duty of candour applies.

7. Documentation and Record-Keeping

Accurate, contemporaneous records are essential to safe pain management and must evidence assessment, action, review and escalation. Staff must record:

the pain assessment tool used and score/observations (including non-verbal indicators)
the person’s own description of pain, triggers, location, intensity, impact on function/sleep/mood, and what helps
consent obtained (or Mental Capacity Act assessment and best-interests rationale where relevant)
interventions provided (non-pharmacological and/or medicines support) including PRN indication and exact time given
response to intervention and reassessment within the timeframe set in the care plan (including “no improvement” and next actions)
any adverse effects, refusals, omissions, or medicines concerns and what was done in response
escalation actions taken, advice received, and outcomes (including communications with healthcare professionals and relevant persons where appropriate)

Records must be completed on the day of care delivery, stored securely, and used to identify trends (e.g., increasing pain, repeated PRN use), prompting clinical review and care plan updates.

8. Staff Training and Competency Development

To ensure effective pain management, all care staff receive comprehensive training that includes:

Recognising and assessing different types of pain.
Using standardised pain assessment tools.
Implementing person-centred pain management strategies.
Safe medication handling and administration.
Responding to service users experiencing distress due to pain.
Understanding ethical and legal considerations in pain management.
Consent and Mental Capacity Act application in pain assessment and pain interventions (including best-interests decisions and documentation).
Recognising deterioration/red flags and correct escalation pathways (including emergency response).
PRN analgesia protocols, medicines risk management, and monitoring for adverse effects (especially opioids and sedating medicines).
Duty of candour awareness and documentation requirements following notifiable safety incidents.
Communication and reasonable adjustments for people with dementia, sensory impairment, learning disability and autistic people, including use of observational pain tools and role-appropriate learning disability/autism training requirements.

Annual refresher courses and competency assessments are conducted to maintain high standards of care.

9. Monitoring and Continuous Improvement

Our organisation ensures ongoing evaluation and enhancement of pain management practices through:

Regular audits of pain assessment records and care plans.
Service user feedback surveys to evaluate pain management effectiveness.
Incident reporting and reviews of pain-related complaints or adverse reactions.
Staff performance reviews to assess knowledge and competency in pain management.
Collaboration with healthcare professionals to ensure best practices are implemented.

Monitoring will be structured to evidence compliance against CQC’s current assessment approach (Single Assessment Framework) and relevant quality statements. Audits will include (as applicable): completeness of pain assessments; evidence of consent/capacity decisions; PRN protocol availability and correct use; reassessment after interventions; appropriate escalation; adverse effect monitoring; and learning from incidents/complaints with actions tracked to completion.

10. Incidents, Duty of Candour and Safeguarding

Pain management can involve notifiable safety incidents, including (not limited to) medicines errors causing harm, avoidable delays in escalation resulting in harm, or adverse effects that were not recognised/escalated appropriately. Where a notifiable safety incident occurs, the organisation will meet its duty of candour by being open and transparent with the service user and/or relevant person, providing an apology, explaining what is known, offering appropriate support, and keeping a clear written record of all actions and communications.

Any concern that unmanaged pain is linked to neglect, inappropriate restriction, coercion, medication misuse, or other abuse/neglect must be treated as a safeguarding concern and escalated in line with the Safeguarding Policy and local authority procedures.

11. Review and Policy Updates

This policy is reviewed annually or whenever significant updates in pain management practices or regulatory guidelines arise. Amendments are made as necessary to ensure compliance with the latest healthcare standards.

12. Conclusion

By implementing this Pain Assessment and Management Policy, our domiciliary care service ensures that all service users receive compassionate, evidence-based pain relief tailored to their individual needs. Our structured assessment framework, multidisciplinary management approach, and commitment to staff training enable us to deliver high-quality, person-centred care while maintaining compliance with CQC standards and regulatory requirements.

Responsible Person: {{org_field_registered_manager_first_name}} {{org_field_registered_manager_last_name}}
Reviewed on: {{last_update_date}}
Next Review Date: {{next_review_date}}
Copyright © {{current_year}} – {{org_field_name}}. All rights reserved.